Canary Staked INJ ETF Files S-1/A, Eyes Staking Rewards

Canary Staked Inj Etf S-1/A Filing Summary
Field	Detail
Company	Canary Staked Inj Etf
Form Type	S-1/A
Filed Date	Dec 17, 2025
Risk Level	high
Pages	15
Reading Time	18 min
Sentiment	mixed

Sentiment: mixed

Topics: Cryptocurrency ETF, Staking Rewards, Injective Protocol, Digital Assets, Proof-of-Stake, SEC Filing, High Risk Investment

TL;DR

**This INJ ETF is a high-risk, high-reward play on crypto staking, but don't expect traditional fund protections.**

AI Summary

The Canary Staked INJ ETF filed an S-1/A on December 17, 2025, aiming to provide exposure to the price of Injective (INJ) and earn additional INJ through a staking program. The Trust will hold INJ and establish its Net Asset Value (NAV) using the CoinDesk Injective USD CCIXber 60m New York Rate. Canary Capital Group LLC is the Sponsor, and BitGo Trust Company, Inc. is the Custodian for the Trust's INJ. The Sponsor will administer the Staking Program, aiming to stake all of the Trust's INJ through a Staking Provider, except for amounts reserved for redemptions or expenses. Staking rewards will be earned through transaction validation on the Injective Network's proof-of-stake blockchain. The Trust will not engage in staking directly but through service providers, with the Custodian maintaining exclusive control of private keys. Staking involves risks like slashing for validator misbehavior and a 21-day dedelegation period where INJ is locked and earns no rewards. Staking rewards will be subject to Staking Fees shared among the Staking Provider, Sponsor, and Custodian.

Why It Matters

This S-1/A filing signals the impending launch of a new exchange-traded product offering direct exposure to Injective (INJ) and its staking rewards, potentially attracting a new class of institutional and retail investors to the INJ ecosystem. For investors, it provides a regulated, traditional brokerage account avenue to access INJ without direct custody risks, though it introduces new risks related to staking and ETF structure. Employees of Canary Capital Group and its service providers could see increased activity and potential growth. The broader crypto market will watch closely as this product competes with other digital asset ETFs, potentially setting a precedent for staked crypto products and influencing the competitive landscape for digital asset investment vehicles.

Risk Assessment

Risk Level: high — The filing explicitly states, 'AN INVESTMENT IN THE TRUST INVOLVES SIGNIFICANT RISKS AND MAY NOT BE SUITABLE FOR SHAREHOLDERS WHO ARE NOT IN A POSITION TO ACCEPT MORE RISK THAN MAY BE INVOLVED WITH EXCHANGE-TRADED PRODUCTS THAT DO NOT HOLD INJ. THE SHARES ARE SPECULATIVE SECURITIES. THEIR PURCHASE INVOLVES A HIGH DEGREE OF RISK AND YOU COULD LOSE YOUR ENTIRE INVESTMENT.' Additionally, the Trust is not registered under the 1940 Act, nor is the Sponsor regulated by the Advisers Act or CFTC, meaning investors lack significant regulatory protections.

Analyst Insight

Investors should conduct extensive due diligence on the specific risks associated with INJ, the Injective Network's proof-of-stake mechanism, and the Staking Program's fee structure before considering an investment. Given the 'high degree of risk' and lack of traditional regulatory protections, this ETF is suitable only for sophisticated investors with a high-risk tolerance who understand the potential for complete loss.

Financial Highlights

total Assets: Not Disclosed
total Debt: Not Disclosed

Key Numbers

10,000 Shares — Basket size (The number of Shares comprising a Basket for creation and redemption)
21-day — Dedelegation period (The temporary lock-up period for staked INJ during which it is inaccessible and earns no rewards)
4:00 p.m. Eastern time — Pricing Benchmark calculation time (The daily time at which the Trust's NAV is calculated)
60-minute — Time-weighted average price (The duration used by CoinDesk Indices to calculate the Pricing Benchmark)

Key Players & Entities

Canary Staked INJ ETF (company) — Registrant and exchange-traded product
Canary Capital Group LLC (company) — Sponsor of the Trust
Injective (company) — Underlying digital asset (INJ)
BitGo Trust Company, Inc. (company) — Custodian for the Trust's INJ
CoinDesk Indices (company) — Benchmark Provider for the Pricing Benchmark
Cboe BZX Exchange, Inc. (company) — Expected listing exchange for the Shares
U.S. Bancorp Fund Services, LLC (company) — Transfer Agent and Cash Custodian
CSC Delaware Trust Company (company) — Trustee of the Trust
Morrison C. Warren, Esq. (person) — Legal counsel from Chapman and Cutler LLP
James Audette, Esq. (person) — Legal counsel from Chapman and Cutler LLP

FAQ

What is the primary investment objective of the Canary Staked INJ ETF?

The primary investment objective of the Canary Staked INJ ETF is to provide exposure to the price of Injective (INJ) held by the Trust, less the expenses of the Trust's operations and other liabilities. A secondary objective is to earn additional INJ through participation in a staking program.

Who is the Sponsor of the Canary Staked INJ ETF and what are their responsibilities?

Canary Capital Group LLC is the Sponsor of the Canary Staked INJ ETF. The Sponsor is responsible for administering the Staking Program and will seek to stake all of the Trust's INJ through one or more staking providers, except for amounts reserved for redemptions or expenses.

How will the Net Asset Value (NAV) of the Canary Staked INJ ETF be determined?

The Net Asset Value (NAV) of the Canary Staked INJ ETF will be established by reference to the CoinDesk Injective USD CCIXber 60m New York Rate, which is calculated by CoinDesk Indices based on a 60-minute time-weighted average price of the INJ-USD CCIXber Reference Rate.

What are the key risks associated with staking INJ for the Canary Staked INJ ETF?

Key risks include 'slashing,' where staked INJ is subject to automatic penalties for validator misbehavior like double-signing or extended downtime. Additionally, there is a 21-day dedelegation period during which previously delegated INJ is locked, inaccessible, and does not earn staking rewards.

Is the Canary Staked INJ ETF regulated under the Investment Company Act of 1940?

No, the Canary Staked INJ ETF is not a fund registered under the Investment Company Act of 1940 and is not subject to regulation under the 1940 Act. Investors will not receive the regulatory protections afforded by funds registered under this act.

Who will hold the Trust's INJ assets and what insurance is provided?

BitGo Trust Company, Inc. will hold all of the Trust's INJ as the Custodian. The Custodian is not insured by the Federal Deposit Insurance Corporation (FDIC) but carries private insurance shared among all customers, which may not be sufficient for all possible losses.

How do investors buy and sell shares of the Canary Staked INJ ETF?

Shareholders will place trade orders through their brokers on the secondary market and will incur customary brokerage commissions and charges. Shares are expected to be listed for trading on Cboe BZX Exchange, Inc. under a ticker symbol yet to be announced.

Will the Canary Staked INJ ETF use leverage or derivatives?

No, the Trust will not utilize leverage, derivatives, or any similar arrangements in seeking to meet its investment objectives. It also will not loan or pledge the Trust's assets.

What are 'Staking Fees' and who receives them in the Canary Staked INJ ETF?

Staking Fees are amounts owed or paid by the Trust for the Staking Program. These fees will vary based on charges by the Staking Provider and will be shared among the Staking Provider, the Sponsor, and the Custodian.

What is the role of the Seed Capital Investor in the Canary Staked INJ ETF?

The Seed Capital Investor, an affiliate of the Sponsor, purchased one Seed Share and later Seed Baskets, representing all outstanding shares as of the prospectus date. This investor will act as a statutory underwriter in connection with the Seed Baskets.

Risk Factors

Volatility of INJ Price [high — market]: The Trust's performance is directly tied to the price of Injective (INJ), which is subject to extreme volatility and price fluctuations characteristic of digital assets. This volatility can lead to significant losses for investors, as the value of the Trust's holdings can decrease rapidly.
Staking Program Risks [medium — operational]: The Trust relies on a Staking Program administered by the Sponsor and executed through a Staking Provider. Risks include slashing penalties for validator misbehavior, which could result in the loss of staked INJ, and the 21-day dedelegation period where staked INJ is inaccessible and earns no rewards, impacting liquidity and potential returns.
Custodian and Private Key Security [high — operational]: While BitGo Trust Company, Inc. is the Custodian and maintains exclusive control of private keys, any security breach or operational failure at the Custodian could jeopardize the Trust's INJ holdings. The Trust's assets are not insured against loss due to such events.
Uncertain Regulatory Environment [high — regulatory]: The digital asset and staking industry faces evolving and uncertain regulatory landscapes globally. Changes in regulations could adversely affect the Trust's ability to operate, the value of INJ, or the staking program, potentially leading to significant losses.
Staking Fees and Reward Dilution [medium — financial]: Staking rewards are subject to Staking Fees shared among the Staking Provider, Sponsor, and Custodian. These fees will reduce the net staking rewards earned by the Trust, impacting overall returns. The exact fee structure is not detailed but will reduce the yield.
Reliance on Pricing Benchmark [medium — market]: The Trust's Net Asset Value (NAV) is calculated using the CoinDesk Injective USD CCIXber 60m New York Rate. Any inaccuracies, manipulation, or unavailability of this benchmark could lead to mispricing of the Trust's shares.

Industry Context

The digital asset ETF market is rapidly evolving, with increasing institutional interest in gaining exposure to cryptocurrencies like Injective. However, the industry faces significant regulatory scrutiny and operational complexities related to custody, staking, and price discovery. Competitors include other crypto-focused ETFs and direct investment vehicles, each navigating similar challenges in security, compliance, and market volatility.

Regulatory Implications

The filing and operation of the Canary Staked INJ ETF are subject to evolving regulations governing digital assets and investment funds. Compliance with securities laws, particularly concerning disclosures and investor protection, is paramount. The staking component introduces additional regulatory considerations related to yield generation and potential classification as a security.

What Investors Should Do

Thoroughly review the 'Risk Factors' section of the S-1/A filing.
Evaluate the impact of Staking Fees on potential returns.
Assess personal risk tolerance for highly volatile digital assets.
Monitor the regulatory landscape for digital assets and staking.

Key Dates

2025-12-17: Filing of S-1/A — Indicates the Trust's intention to offer shares to the public, providing details on its investment strategy, risks, and operational structure.

Glossary

Injective (INJ): The native cryptocurrency of the Injective blockchain, which the Trust aims to provide exposure to. (The primary underlying asset for the Trust's investment strategy and staking rewards.)
Staking Program: A process where the Trust's INJ holdings are delegated to validators on the Injective Network to earn staking rewards in exchange for supporting network security and operations. (The mechanism through which the Trust aims to generate additional INJ yield beyond price appreciation.)
Net Asset Value (NAV): The per-share market value of the Trust's assets, calculated daily based on the price of INJ. (Determines the value of the Trust's shares for creation, redemption, and investor reporting.)
CoinDesk Injective USD CCIXber 60m New York Rate: The specific benchmark rate used by CoinDesk Indices to determine the price of Injective (INJ) for NAV calculation. (The official pricing source for the Trust's underlying asset, impacting NAV accuracy.)
Dedelegation Period: A mandatory lock-up period of 21 days after unstaking INJ, during which the assets are inaccessible and do not earn rewards. (Represents a liquidity constraint and a period of zero yield for a portion of the Trust's staked assets.)
Slashing: Penalties imposed on validators in proof-of-stake networks for malicious behavior or downtime, resulting in the loss of staked cryptocurrency. (A key risk associated with the staking program that could lead to a direct loss of the Trust's INJ holdings.)
Basket: A standard block of 10,000 Shares used by Authorized Participants for the creation and redemption process of ETF shares. (Defines the unit of trading for large-scale creation and redemption activities, impacting ETF liquidity.)

Year-Over-Year Comparison

As this is the initial S-1/A filing, there is no prior filing to compare against. Key metrics such as revenue, margins, and specific risk factor evolution will only become available after the ETF has been operational and subsequent filings are made.

Filing Stats: 4,423 words · 18 min read · ~15 pages · Grade level 15 · Accepted 2025-12-17 17:27:22

Filing Documents

inj-s1a_121725.htm (S-1/A) — 1151KB
0001999371-25-020561.txt ( ) — 1152KB

RISK FACTORS

RISK FACTORS 21 THE TRUST AND SEI PRICES 61 CALCULATION OF NAV 65 ADDITIONAL INFORMATION ABOUT THE TRUST 67 THE TRUST’S SERVICE PROVIDERS 70 CUSTODY OF THE TRUST’S ASSETS 74 FORM OF SHARES 76 TRANSFER OF SHARES 76 SEED CAPITAL INVESTOR 76 PLAN OF DISTRIBUTION 77 CREATION AND REDEMPTION OF SHARES 78

USE OF PROCEEDS

USE OF PROCEEDS 83 83 CONFLICTS OF INTEREST 84 DUTIES OF THE SPONSOR 85 LIABILITY AND INDEMNIFICATION 87 PROVISIONS OF LAW 89 MANAGEMENT; VOTING BY SHAREHOLDERS 89 BOOKS AND RECORDS 90 90 FISCAL YEAR 91 GOVERNING LAW; CONSENT TO DELAWARE JURISDICTION 91 LEGAL MATTERS 91 EXPERTS 91 MATERIAL CONTRACTS 91 UNITED STATES FEDERAL INCOME TAX CONSEQUENCES 95 PURCHASES BY EMPLOYEE BENEFIT PLANS 100 INFORMATION YOU SHOULD KNOW 101 INTELLECTUAL PROPERTY 101 WHERE YOU CAN FIND MORE INFORMATION 102 PRIVACY POLICY 102 Report of Independent Registered Public Accounting Firm 103 This Prospectus contains information you should consider when making an investment decision about the Shares of the Trust. You may rely on the information contained in this Prospectus. The Trust and the Sponsor have not authorized any person to provide you with different information and, if anyone provides you with different or inconsistent information, you should not rely on it. This Prospectus is not an offer to sell the Shares in any jurisdiction where the offer or sale of the Shares is not permitted. The Shares of the Trust are not registered for public sale in any jurisdiction other than the United States. i REGARDING FORWARD-LOOKING STATEMENTS This Prospectus includes “forward-looking statements” that generally relate to future events or future performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or the negative of these terms or other comparable terminology. All statements (other than statements of historical fact) included in this Prospectus that address a

View Full Filing

View this S-1/A filing on SEC EDGAR